Literature DB >> 7377381

Quantitative aspects of reversible osmotic opening of the blood-brain barrier.

S I Rapoport, W R Fredericks, K Ohno, K D Pettigrew.   

Abstract

Retrograde infusion of a hypertonic arabinose solution into the right external carotid artery of rats reversibly increases cerebrovascular permeability to [14C]sucrose in the right cerebral hemisphere. PA ([14C]sucrose permeability x capillary surface area) rises from a control mean of 11 x 10(-6) S-1 to above 200 x 10(-6) S-1. The rise correlates with an increased staining of the brain by intravascular Evans blue, and is followed by a transient, 1-1.5% increase in brain water content. At least 20 s of infusion is required for 1.6 M arabinose solution to effectively open the blood-brain barrier. The increase in cerebrovascular permeability is temporary, however, because PA remains slightly elevated 1-2 h after infusion and is normal 6 h after infusion. It is suggested that osmotic barrier opening is mediated by cerebrovascular dilatation as well as by shrinkage of the vascular endothelium. By quantitatively defining thresholds of infusate concentration and infusion time for osmotic barrier opening, and by characterizing the time course of increased PA, the experiments establish criteria for applying the osmotic method to experimental pharmacology of the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7377381     DOI: 10.1152/ajpregu.1980.238.5.R421

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  54 in total

Review 1.  The blood-brain barrier and bilirubin encephalopathy.

Authors:  R P Wennberg
Journal:  Cell Mol Neurobiol       Date:  2000-02       Impact factor: 5.046

Review 2.  Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications.

Authors:  S I Rapoport
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

Review 3.  Intra-arterial chemotherapy for malignant gliomas: a critical analysis.

Authors:  J-K Burkhardt; H A Riina; B J Shin; J A Moliterno; C P Hofstetter; J A Boockvar
Journal:  Interv Neuroradiol       Date:  2011-10-17       Impact factor: 1.610

4.  Potential role of cerebral glutathione in the maintenance of blood-brain barrier integrity in rat.

Authors:  R Agarwal; G S Shukla
Journal:  Neurochem Res       Date:  1999-12       Impact factor: 3.996

5.  Reactive changes of retinal microglia during fatal murine cerebral malaria: effects of dexamethasone and experimental permeabilization of the blood-brain barrier.

Authors:  I M Medana; T Chan-Ling; N H Hunt
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

6.  MR imaging findings of cortical blindness following cerebral angiography: is this entity related to posterior reversible leukoencephalopathy?

Authors:  Sait Albayram; Harun Ozer
Journal:  AJNR Am J Neuroradiol       Date:  2005-01       Impact factor: 3.825

7.  Blood-brain barrier damage and brain penetration of antiepileptic drugs: role of serum proteins and brain edema.

Authors:  Nicola Marchi; Giulia Betto; Vincent Fazio; Quinyuan Fan; Chaitali Ghosh; Andre Machado; Damir Janigro
Journal:  Epilepsia       Date:  2009-01-21       Impact factor: 5.864

8.  Repeated Forced Swim Exacerbates Methamphetamine-Induced Neurotoxicity: Neuroprotective Effects of Nanowired Delivery of 5-HT3-Receptor Antagonist Ondansetron.

Authors:  José Vicente Lafuente; Aruna Sharma; Dafin F Muresanu; Asya Ozkizilcik; Z Ryan Tian; Ranjana Patnaik; Hari S Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

9.  Capillary junctions of the rat are not affected by osmotic opening of the blood-brain barrier.

Authors:  C L Farrell; R R Shivers
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

10.  Transvascular Delivery of Hydrophobically Modified siRNAs: Gene Silencing in the Rat Brain upon Disruption of the Blood-Brain Barrier.

Authors:  Bruno M D C Godinho; Nils Henninger; James Bouley; Julia F Alterman; Reka A Haraszti; James W Gilbert; Ellen Sapp; Andrew H Coles; Annabelle Biscans; Mehran Nikan; Dimas Echeverria; Marian DiFiglia; Neil Aronin; Anastasia Khvorova
Journal:  Mol Ther       Date:  2018-08-08       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.